Literature DB >> 7151845

The electrocardiographic and anticholinergic effects of trazodone and imipramine in man.

C D Burgess, T K Hames, C F George.   

Abstract

The electrocardiographic and anticholinergic effects of trazodone (150 mg) and imipramine (75 mg) were investigated in 8 healthy volunteers. Both agents increased the QTc interval and decreased T wave height, but the effects occurred earlier with trazodone (from 30 min onwards) than with imipramine (150 and 180 min after dosing). Both drugs decreased heart rate, imipramine at 30 and 60 min and trazodone at 90 min. After 120 min, heart rate began to increase with imipramine an effect which was not seen with trazodone. Salivary volume was significantly decreased by imipramine at 120 and 180 min whereas trazodone did not influence salivary volume. Plasma levels of trazodone and imipramine were significantly related to the decrease in T wave amplitude. The increase in QTc interval correlated significantly with the plasma level of imipramine. These results suggest that trazodone, like the tricyclic antidepressants prolongs ventricular repolarization; but, in contrast to imipramine, it does not have anticholinergic activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7151845     DOI: 10.1007/bf00605991

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  22 in total

1.  Adrenergic and cholinergic influences on the dynamic cycle of the normal human heart.

Authors:  W RAAB; P DE PAULA E SILVA; Y K STARCHESKA
Journal:  Cardiologia       Date:  1958

2.  Clinical features in poisonings by tricyclic antidepressants with special reference to the ECG.

Authors:  C Thorstrand
Journal:  Acta Med Scand       Date:  1976

3.  The effect of oral quinidine on intraventricular conduction in man: correlation of plasma quinidine with changes in QRS duration.

Authors:  R H Heissenbuttel; J T Bigger
Journal:  Am Heart J       Date:  1970-10       Impact factor: 4.749

4.  Cardiac antiarrhythmic effect of imipramine hydrochloride.

Authors:  J T Bigger; E G Giardina; J M Perel; S J Kantor; A H Glassman
Journal:  N Engl J Med       Date:  1977-01-27       Impact factor: 91.245

Review 5.  Effects of clomipramine and other tricyclic antidepressants on biogenic amine uptake and turnover.

Authors:  P C Waldmeier; P Baumann; P M Greengrass; L Maître
Journal:  Postgrad Med J       Date:  1976       Impact factor: 2.401

6.  Trazodone, a new nontricyclic antidepressant without anticholinergic activity.

Authors:  D P Taylor; D K Hyslop; L A Riblet
Journal:  Biochem Pharmacol       Date:  1980-08-01       Impact factor: 5.858

7.  Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia.

Authors:  J Hulting; G Rosenhamer
Journal:  J Int Med Res       Date:  1976       Impact factor: 1.671

8.  Cardiovascular effects of amitriptyline, mianserin, zimelidine and nomifensine in depressed patients.

Authors:  C D Burgess; S Montgomery; J Wadsworth; P Turner
Journal:  Postgrad Med J       Date:  1979-10       Impact factor: 2.401

9.  Tricyclic antidepressant toxicity.

Authors:  J B Rose
Journal:  Clin Toxicol       Date:  1977       Impact factor: 4.467

10.  Comparative effects of imipramine and dothiepin on salivary rate in normal volunteers.

Authors:  U K Sheth; T Paul; N K Desai; P K Pispati
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335

View more
  6 in total

1.  Trazodone--a comparison of single night-time and divided daily dosage regimens.

Authors:  D Brooks; W Prothero; N Bouras; P K Bridges; C M Jarman; S I Ankier
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

2.  Interaction of alcohol with maprotiline or nomifensine: echocardiographic and psychometric effects.

Authors:  C Strömberg; A Suokas; T Seppälä
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 3.  Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders.

Authors:  M Haria; A Fitton; D McTavish
Journal:  Drugs Aging       Date:  1994-04       Impact factor: 3.923

Review 4.  Rediscovering trazodone for the treatment of major depressive disorder.

Authors:  Andrea Fagiolini; Alessandro Comandini; Mario Catena Dell'Osso; Siegfried Kasper
Journal:  CNS Drugs       Date:  2012-12       Impact factor: 5.749

Review 5.  Pain medication and long QT syndrome.

Authors:  Christoph Klivinyi; Helmar Bornemann-Cimenti
Journal:  Korean J Pain       Date:  2018-01-02

6.  Effect of 3 Single Doses of Trazodone on QTc Interval in Healthy Subjects.

Authors:  Valeria Tellone; Maria Teresa Rosignoli; Rossella Picollo; Patrizia Dragone; Alessandra Del Vecchio; Alessandro Comandini; Milko Radicioni; Chiara Leuratti; Fabrizio Calisti
Journal:  J Clin Pharmacol       Date:  2020-06-02       Impact factor: 3.126

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.